Growing bench of proven leaders in clinical lung intelligence and health technology bolsters both product and commercial advances Coralville, IA (August 11, 2020) —VIDA Diagnostics, Inc. (“VIDA”), the leader in lung and respiratory intelligence, announced today that it is has appointed Karen Drexler to its board of directors, further expanding the
Todd Johnson joins VIDA, bringing expertise in enterprise imaging, clinical software applications to growing bench of experts for AI-powered pulmonary imaging company Coralville, IA (July 7, 2020) — VIDA Diagnostics, Inc. (“VIDA”), the leader in AI-powered lung imaging analysis, announced today that Todd Johnson has joined the company as chief
$2M Second Close from Strategic Partners Completes $13M C Round to Advance AI-Powered Respiratory Solutions Coralville, IA (April 15, 2020) — VIDA Diagnostics, Inc. (“VIDA”), the leader in AI-powered lung imaging analysis, received $2M from OSF Ventures, the corporate investment arm of OSF HealthCare, as a second close of its C
VIDA provides personalized care solutions that can help pulmonologists identify specific disease phenotypes as well as decide on the most appropriate treatments Note: The following press release was issued by Frost and Sullivan on April 1, 2020 and is republished here in full. SANTA CLARA, Calif., April 1, 2020 /CNW/ -- Based
Coralville, IA (March 12, 2020) — VIDA Diagnostics, Inc. (“VIDA”), the leader in AI-powered lung imaging analysis, today announced an $11M initial close of its Series C financing. The investment was led by First Analysis Corporation with initial equity participation from Blue Heron Capital and UnityPoint Health Ventures. Existing investors including
Coralville, IA (October 14, 2019) — VIDA Diagnostics, Inc. (“VIDA”), the leader in AI-powered lung imaging analysis, announced a distribution agreement with TeraRecon, Inc., a leader in advanced visualization, artificial intelligence, image viewing, and post-processing. With this agreement, VIDA’s LungPrint® analysis will be available through TeraRecon’s AI Interoperability platform, EnvoyAI, expanding
CORALVILLE, Iowa, Oct. 4, 2019 /PRNewswire/ -- VIDA Diagnostics, Inc. ("VIDA"), the leader in AI-powered lung imaging analysis, today announced the appointment of Erkan Akyuz as independent director. Mr. Akyuz will join VIDA's Board of Directors to help guide the company's growth initiatives with differentiated healthcare IT leadership and market expertise. Mr. Akyuz is the President
$1M Investment Combined with Support from the State of Iowa Represents a Shared Vision to Transform Health Care through AI-Powered Innovation Coralville, IA (July 25, 2019) — VIDA Diagnostics, Inc. (VIDA) today announced a strategic partnership and investment from UnityPoint Health Ventures, part of the innovation arm of Iowa’s largest
CORALVILLE, Iowa, June 25, 2019 /PRNewswire/ -- VIDA Diagnostics, Inc. ("VIDA"), the leader in pulmonary imaging analytics, today announced it has joined the Nuance AI Marketplace for Diagnostic Imaging as a technology partner. With this agreement, VIDA's LungPrint® Discovery analysis will be available through the Nuance AI Marketplace to 70 percent of all radiologists across
